Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2020 3
2021 2
2022 2
2023 3
2024 3
2025 5
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Mortality risk in migrant and non-migrant individuals with chronic hepatitis B virus infection: a French hospital-based cohort study (ANRS CO22 HEPATHER).
Lotto M, Ramier C, Carrat F, Périères L, Delaroque-Astagneau E, Nicol J, Marcellin F, Zoulim F, Di Beo V, Bertheau M, Pol S, Protopopescu C, Bourlière M, Carrieri P; ANRS/AFEF CO22 HEPATHER Study Group. Lotto M, et al. BMC Glob Public Health. 2025 Jul 1;3(1):58. doi: 10.1186/s44263-025-00173-7. BMC Glob Public Health. 2025. PMID: 40598581 Free PMC article.
Extrahepatic portal vein obstruction (EHPVO) in cirrhosis.
Abergel A, Gasperment M, Nery FG, Buchard B, Lebreton A, Hordonneau C, Duron C, Valla D, Sophie H, Ledain-Rautou E, Hernandez-Gea V, Dutheil D, Plessier A, Bureau C, Francoz C. Abergel A, et al. Among authors: buchard b. Clin Res Hepatol Gastroenterol. 2020 Sep;44(4):497-502. doi: 10.1016/j.clinre.2020.03.014. Epub 2020 Apr 17. Clin Res Hepatol Gastroenterol. 2020. PMID: 32312599 No abstract available.
Noninvasive biomarkers of non-alcoholic fatty liver disease in patients with metabolic syndrome: insights from the RESOLVE Study.
Ennequin G, Buchard B, Pereira B, Bonjean L, Courteix D, Lesourd B, Chapier R, Obert P, Vinet A, Walther G, Zak M, Bagheri R, Ugbolue CU, Abergel A, Dutheil F, Thivel D. Ennequin G, et al. Among authors: buchard b. Minerva Gastroenterol (Torino). 2023 Dec;69(4):494-503. doi: 10.23736/S2724-5985.22.03139-4. Epub 2022 Feb 10. Minerva Gastroenterol (Torino). 2023. PMID: 35144365
Evaluation of a delayed liver transplantation strategy for patients with HCC receiving bridging therapy: the DELTA-HCC study.
Lamarque C, Segaux L, Bachellier P, Buchard B, Chermak F, Conti F, Decaens T, Dharancy S, Di Martino V, Dumortier J, Francoz-Caudron C, Gugenheim J, Hardwigsen J, Muscari F, Radenne S, Salamé E, Uguen T, Ursic-Bedoya J, Antoine C, Deshayes A, Jacquelinet C, Natella PA, Leroy V, Cherqui D, Oubaya N, Duvoux C. Lamarque C, et al. Among authors: buchard b. J Hepatol. 2024 Aug;81(2):278-288. doi: 10.1016/j.jhep.2024.03.019. Epub 2024 Mar 21. J Hepatol. 2024. PMID: 38521171 Free article.
Phase 3, Multicenter Open-Label study to investigate the efficacy of elbasvir and grazoprevir fixed-dose combination for 8 weeks in treatment-naïve, HCV GT1b-infected patients, with non-severe fibrosis.
Abergel A, Asselah T, Mallat A, Chanteranne B, Faure F, Larrey D, Gournay J, Loustaud-Ratti V, Di Martino V, Fouchard-Hubert I, Pol S, Bailly F, Samuel D, Tran A, Dodel M, Andant N, Lamblin G, Muti L, Reymond M, Teilhet C, Pereira B, Buchard B. Abergel A, et al. Among authors: buchard b. Liver Int. 2020 Aug;40(8):1853-1859. doi: 10.1111/liv.14502. Epub 2020 Jun 1. Liver Int. 2020. PMID: 32383275 Clinical Trial.
17 results